The Evaluation of the Drug R3R01 for the Excretion of Protein in the Urine in Patients With Diabetic Kidney Disease.
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2025-04-02
- Lead Sponsor
- River 3 Renal Corp.
- Target Recruit Count
- 60
- Registration Number
- NCT06600412
- Locations
- 🇩🇰
Steno Diabetes Center Copenhagen, Copenhagen, Denmark
Study to Evaluate R3R01 in Patients With Alport Syndrome and Patients With Focal Segmental Glomerulosclerosis
Phase 2
Active, not recruiting
- Conditions
- Focal Segmental GlomerulosclerosisAlport Syndrome
- Interventions
- First Posted Date
- 2022-03-04
- Last Posted Date
- 2025-04-25
- Lead Sponsor
- River 3 Renal Corp.
- Target Recruit Count
- 50
- Registration Number
- NCT05267262
- Locations
- 🇺🇸
Investigative Site, Dallas, Texas, United States
🇬🇧Investigative site, Nottingham, United Kingdom
© Copyright 2025. All Rights Reserved by MedPath